In one of medicine's most ambitious experiments, 142,000 people across England offered their blood to a question humanity has long wanted answered: can a single test find cancer before it finds us? The NHS-Galleri trial, now publishing its first results in the world's leading journals, offers an answer that is neither triumph nor defeat — the test sees some cancers earlier, but has not yet proven it can reduce the burden of advanced disease that claims so many lives. It is the nature of genuine scientific progress to arrive not as revelation but as a more precise map of what remains unknown.